Skip to main content
Livermore
Livermore
ZHEN

Trexquant Investment LP

SEC CIK
0001633445
Latest filing
Aug 14, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Trexquant Investment LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q2 2026)
121,091
Value
$741.1K
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of VNDA by Trexquant Investment LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026121,091$741.1K<0.1%+31,806+35.6%AddedHolders
Q1 202689,285$617.0K<0.1%−115,206−56.3%ReducedHolders
Q4 2025204,491$1.80M<0.1%+204,491NewHolders
Q2 20250$00.0%−192,110−100.0%Sold outHolders
Q1 2025192,110$881.8K<0.1%−34,566−15.2%ReducedHolders
Q4 2024226,676$1.09M<0.1%+22,229+10.9%AddedHolders
Q3 2024204,447$958.9K<0.1%+132,613+184.6%AddedHolders
Q2 202471,834$405.9K<0.1%+71,834NewHolders
Q1 20240$00.0%−104,511−100.0%Sold outHolders
Q4 2023104,511$441.0K<0.1%−169,741−61.9%ReducedHolders
Q3 2023274,252$1.18M<0.1%+262,088+2,154.6%AddedHolders
Q2 202312,164$80.2K<0.1%−37,293−75.4%ReducedHolders
Q1 202349,457$335.8K<0.1%−12,285−19.9%ReducedHolders
Q4 202261,742$456.3K<0.1%+29,820+93.4%AddedHolders
Q3 202231,922$315.0K<0.1%+2,948+10.2%AddedHolders
Q2 202228,974$316.0K<0.1%−41,203−58.7%ReducedHolders
Q1 202270,177$794.0K<0.1%+41,254+142.6%AddedHolders
Q4 202128,923$454.0K<0.1%+28,923NewHolders
Q2 20210$00.0%−15,393−100.0%Sold outHolders
Q1 202115,393$231.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.